HealiAid in the Treatment of Different Wounds

Status Completed

Clinical Trial Summary

The goal of this open-label, post-market clinical follow-up study is to demonstrate the safety and effectiveness of HealiAid Collagen Wound Dressing in patients classified into different types of wounds: venous ulcers, bedsores, diabetic foot wounds and burn wounds. The main questions it aims to answer are: 1. The wound healing which was defined as the percentage of area change. 2. The duration of wound healing. 3. The granulation tissue growth of the wound. 4. The wound exudate. 5. Safety Indicators of which incidences after treatment. HealiAid will be applied to eligible subjects who will later be followed up for 12 weeks.

Clinical Trial Description

An open-label study will be performed in single center to monitor about 6 patients in each types of wounds: venous ulcers, bedsores, diabetic foot wounds and burn wounds, totally 24 patients, after the treatment of using HealiAid Collagen Wound Dressing (MAXIGEN BIOTECH INC., Taiwan) directly on the wound sites. Follow-up visits will be at 1, 2, 4, 8 and 12(if needed) weeks after the treatment. The primary endpoint of this study was the area percentage of healed wound at the 8-week post-treatment interval, which is also considered as the healing condition of the wound. The secondary endpoints of this study were included the duration of wound healing, granulation tissue growth, wound exudate, and the incidence of safety events. T-test or Wilcoxon rank-sum test will be used to test for the differences between baseline and each visit. Statistical significance was established at p < 0.05. The actual enrollment of this study was 6 participants each in the venous ulcers, bedsores, and burn wounds, while no patients with diabetic foot wounds were recruited, resulting in a total of 18 participants. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06280053
Study type	Interventional
Source	Maxigen Biotech Inc.
Contact
Status	Completed
Phase	N/A
Start date	March 2, 2016
Completion date	October 26, 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03948360` - Safety Study of a Novel Wearable Phototherapy System for the Management of Acute Burn Wounds	N/A
Completed	`NCT04277182` - Effect of Propolis Application on Burn Healing	N/A
Enrolling by invitation	`NCT00978705` - Clinical Efficacy and Safety of Autologous Cultured Keratinocyte Cell on Severe Burn Wood	Phase 3
Withdrawn	`NCT03675568` - Non-cultured Autologous Keratinocyte Suspension Versus Traditional Split Skin Graft for Burn Wounds Treatment	N/A
Active, not recruiting	`NCT04828304` - PLASOMA Ultimate Safety & Efficacy Study	N/A
Not yet recruiting	`NCT05649332` - Study to Evaluate the Performance and Safety of the Medical Device Argogen	N/A
Recruiting	`NCT05593523` - Fluorescence-based Detection of Inflammation and Necrosis to Inform Surgical Decision-making and Enhance Outcomes
Enrolling by invitation	`NCT06103409` - MSCs for the Treatment of Burn Wounds	Phase 1/Phase 2
Recruiting	`NCT05796492` - Ultrasound Treatment on Wound Healing Time	N/A
Enrolling by invitation	`NCT04725071` - Immunonutrition Supplementation for Improved Burn Wound Healing in Older Adults	N/A
Suspended	`NCT02577120` - Wound Healing Endpoint and Recurrence	Phase 4
Active, not recruiting	`NCT05341427` - DEVELOPMENT OF A CLINICAL PREDICTION RULES TO IDENTIFY EFFICACY OF PULSED ELECTROMAGNETIC THERAPY ON BURN WOUND HEALING	N/A
Completed	`NCT04753723` - The Use of a Platform Wound Device for Reducing Infection	Phase 4
Terminated	`NCT03723590` - A Clinical Evaluation of an Esterified Hyaluronic Acid Matrix in Burn Patients for STSG	N/A
Not yet recruiting	`NCT04011306` - A Feasibility Study of a Novel Phototherapy System for the Management of Acute Burns	N/A
Recruiting	`NCT05404191` - Prediction Rules for Low Level Laser on Burn Wounds	N/A
Completed	`NCT02982096` - Study Comparing Healing With Epidermal Fractional Blistergrafting (CellutomeTM) to Acellular Technique	N/A